ILMN

NASDAQ · Life Sciences Tools & Services

Illumina Inc

Large-Cap Stocks Blue Chip Stocks Healthcare Stocks

$212.85

+4.85 (+2.33%)

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 16 57%

Hold 9 32%

Sell 3 11%

Price Target

Analyst Price Target -20.4% upside

Low Target $114.37

Average Target $169.36

High Target $229.23

Current Price $212.85

Current
$212.85

Target
$169.36

$114.37 $169.36 avg $229.23

Scenario Analysis

Bear Case

$114.37

-46.3%

Low target

Base Case

$169.36

-20.4%

Avg target

Bull Case

$229.23

+7.7%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$309.35

-31.2% from high

52-Week Low

$94.00

+126.4% from low

50-Day SMA

$249.77

-14.8% vs SMA

200-Day SMA

$177.39

+20.0% vs SMA

RSI (14)

35.9

Neutral

Target vs 52W High

$169.36

-45.3% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	35	86%	$369.21	-47.0%
DHR Danaher Corp	Strong Buy	31	87%	$158.11	-31.3%
A Agilent Technologies Inc	Buy	29	72%	$64.69	-63.1%
WAT Waters Corp	Buy	30	70%	$189.60	-58.8%
IQV Iqvia Holdings Inc	Strong Buy	27	85%	$82.96	-69.4%
ILMN Illumina Inc	Buy	28	57%	$169.36	-20.4%
MTD Mettler-Toledo International	Hold	19	47%	$170.43	-90.3%
WST West Pharmaceutical Services	Strong Buy	22	95%	$136.24	-66.0%